Please contact Customer Service with any questions. Ph: option 5

Similar documents
Evidence-Based Hematological Solutions

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI

of s and s Disclosure

Nationwide Children s Hospital

10/15/2015. Clinical Utility of Immature Cell Indices DISCUSSION POINTS HEALTHCARE REFORM PAYMENT MODEL EXPERIMENTS

It s Easier Than you Think How to Implement the Advanced Clinical Parameters

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter

LEANING Away Waste and Improving Patient Care with Advances in Hematology

May is Better Sleep Month

Advanced parameters offer faster, surer guidance to cancer care

Notes for the 2 nd histology lab

3/31/2017 OBJECTIVES CASE STUDY #1 MANUAL REVIEW. Hematology Case Studies: Every Picture Tells a Story

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

H. PYLORI AB, IGG HPYL

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Lavender Top Management SUCCESS BEYOND FINANCES

ANEMIA & HEMODIALYSIS

Customer Information Literature List Platelets

HAEMATOLOGICAL MALIGNANCY

The importance of thrombocytopenia and its causes

Faculty of Medicine Dr. Tariq Aladily

Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients

The Complete Blood Count

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition:

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

Lavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision

Hematology: Challenging Cases with Your Participation COPYRIGHT

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Interpath Laboratory, Inc. Test File Update

Cbc with differential

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: TSENG, JUSTINA J DOB: 10/26/1955 AGE: 59

Applying clinical guidelines treating and managing CKD

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

The Evolving Role of Reticulated Platelets

NEW HEMATOLOGY PARAMETERS

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN

Hematopoiesis Simplified: Part 1 Erythropoiesis

ALPS Screen Order Set B-Cell Panel Order Set (% and absolute #) (% and Absolute #) ALPS (CD3+/CD4-/CD8-/TCR αβ+)

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Clinician Blood Panel Results

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Specific Panels. Celiac disease panel. Pancreas Panel:

Introduction and II. Blood Cells A. Introduction

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

PATHOLOGY & PATHOPHYSIOLOGY

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

APPROACHING TO PANCYTOPENIA

Known as EPO MW 30400Da Discovered by Miyake et al 1977from urine of anaemic pts. LC 4 alpha helical bundle class 1 cytokine

Drugs Used in Anemia

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Do Now pg What part of the blood causes a blood clot? 2. Could you survive without this? Why?

Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana

General Characterisctics

Alkaline Phosphatase, Bone Specific

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

* imagine if the Hb is free ( e.g. hemolysis ) in the plasma what happens?

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Hematology Revision. By Dr.AboRashad . Mob

Platelet and WBC disorders

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

Basic Metabolic Panel

XN-SERIES. XN Technology and Case Studies

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).

XN-SERIES. Hematology Case Studies: Every Picture Tells a Story

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS


Continuing Education Questions

Chapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders

INFLUENCE OF LOW PROTEIN DIET IN IMPROVING ANEMIA TREATED WITH ERYTHROPOETIN

To be used for the ease of test requisitioning on select patients only; all components may be ordered separately

Interpath Laboratory, Inc. Test File Update

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Management of anemia in CKD

Clinician Blood Panel Results

PNH Glossary of Terms

9/23/2018. Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES FLUORESCENT FLOW CYTOMETRY


Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

CPT Code: Serum Urea Nitrogen, Urine Urea Nitrogen in mg/dl, 24 hour Urine Urea Nitrogen, Urea Clearance

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None

Myelodysplastic Syndrome: Let s build a definition

Rapid Laboratories In House Tests

TSAT PROJECT Shean Strong, QI Director Lisle Mukai, QI Coordinator

Test Bulletin. Save time, money, resources, and precious blood by NOT collecting extra specimens just in case

FOCUS ON IRON-DEFICIENCY ANEMIA AND ITS TREATMENT

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

Essentials of Human Anatomy and Physiology, 11e (Marieb) Chapter 10 Blood Multiple Choice Part I Questions

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1.

Disease Pathogenesis and Research Progression of Renal Anemia

Hematology Unit Lab 1 Review Material

Effective Health Care Program

Transcription:

Sarasota Memorial Laboratory Services is pleased to announce that we are now performing the following testing in house: Immature Platelet Fraction (IPF) The Immature Platelet Fraction (IPF) is used to monitor thrombopoiesis. The presence of immature platelets (also called Reticulated Platelets) helps to distinguish between bone marrow failure and peripheral platelet consumption or destruction. Provides a direct cellular measurement of thrombopoietic activity Supports determination of the cause/differential diagnosis of thrombocytopenia May help in determining need for prophylactic transfusions Direct measurement of immature platelet production for faster indication of response to therapy Recovery from chemotherapy and/or bone marrow transplant IPF is an indicator of platelet production by the bone marrow and is expressed as a percent of the total platelet count. RET (added with retic order) 0.5 ml of EDTA whole blood Lavender EDTA tube Daily Reference Range 1.1% to 6.1% CPT Code 85046

Anti-CCP Anti-CCP Test Cyclic Citrullinated Peptide (CCP) Used to detect antibodies to RA May be used in combination with clinical findings in the diagnosis of RA. Reference Range CCP 1 ml serum Gold top Tuesday and Thursday 5 U/mL = Negative >5 U/mL = Positive CPT Code 86200

The Reticulocyte Hemoglobin Equivalent (RET-HE) The Reticulocyte Hemoglobin Equivalent (RET-HE) quantifies the hemoglobin content of reticulocytes an aide in assessing iron available for erythropoiesis. Low hemoglobin content in reticulocytes indicates inadequate iron supply relative to demand. In patients with end-stage renal disease (ESRD) iron stores may not be adequate to sustain normal red cell production. RET-HE is useful for: A more comprehensive anemia work up, for early diagnosis of iron deficiency Monitoring iron status of patients with chronic kidney disease on hemodialysis, as well as for monitoring I.V. iron replacement and optimizing iron therapy Monitoring erythropoietin therapy To monitor athletes for use of EPO drugs The RET-HE is an indicator of the amount of hemoglobin in reticulocytes and is expressed as picograms. RET (added with retic order) 0.5 ml of EDTA whole blood Lavender EDTA tube Daily Reference Range 24.1 35.8 pg CPT Code 85046

Immature Granulocyte Percent (IG%) Immature Granulocyte Percent (IG%) is a measurement of metamyelocytes, myelocytes and promyelocytes. (Bands and blasts are not included). Blasts will be reported separately. IG% will be a part of every CBC that is ordered. (No need to order) Anytime the IG% is greater than 5.0% manual review of a smear and/or a manual differential will be performed. with every CBC automatically 1 ml plasma Lavender EDTA tube Daily Reference Range 0-5% CPT Code 85025

Vitamin-D, 25-HYDROXY Low levels are associated with liver disorders, intestinal malabsorption, nephritic syndrome and calcium homeostasis as well as increased mortality including cardiovascular mortality, cancer incidence and mortality, Type 1 diabetes, hypertension, and autoimmune diseases such as multiple sclerosis. Special Instructions VITD25 Best practices related to the clinical lab testing efficacy demonstrate that PTH needs to be measured when 25-hydroxy Vitamin D is deficient. In addition, 1,25 Vit D is of diagnostic value only after elevated PTH has been measured. Physicians will be contacted prior to performing 1,25 Vit D if o The Lab has not received a prior order for Vitamin D, 25- hydroxy o The Vitamin-D, 25-hydroxy results are normal o The Lab has not received a prior order for a PTH o The PTH results are not elevated 1.0 ml serum Gold top Monday-Friday Reference Range Range Level ng/ml Deficient <10 Insufficient 10-29 Sufficient 30-100 Potential Intoxication >100 CPT Code 82306

The Epstein-Barr Virus Antibody Panel (EBV) The Epstein-Barr Virus Antibody Panel (EBV): consists of 4 components: VCA-IGG VCA-IGM EA-IGG EBNA Specimen Requirements Interpretation EBV 0.5 ml serum Gold top Monday, Wednesday and Friday The Epstein-Barr Virus Antibody Panel Interpretation: VCA- VCA- EA- EBNA IGG IGM IGG Susceptible - - - - Acute infection + + ± - Convalescent phase + ± ± + Chronic or reactivated + - + ± Old infection ± - - + CPT Code 86665 x 2, 86664, 86663